스페인 호흡기 기기 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the Spain respiratory devices market size was valued at USD 639.77 million in 2025 and estimated to grow from USD 681.23 million in 2026 to reach USD 933.05 million by 2031, at a CAGR of 6.49% during the forecast period (2026-2031).

This report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic Devices, Disposables), Indication (COPD, Asthma, Sleep Apnea, Cystic Fibrosis, Tuberculosis, Other Respiratory Disorders), End User (Hospitals and Clinics, Homecare Settings, Ambulatory Surgical Centers, Long-Term Care Facilities), and Geography (Spain). The Market Forecasts are Provided in Terms of Value (USD).

Spain Respiratory Devices Market Trends and Insights

Growing Prevalence of COPD, Asthma, Tuberculosis, and Sleep Apnea

COPD affects 11.8% of Spanish adults and drove a 35.9% rise in hospital discharges for respiratory diseases, a pattern that strengthens long-term sales of ventilators, nebulizers, and spirometers. Sleep apnea remains widely underdiagnosed despite affecting nearly half of older adults at elevated dementia risk, creating fresh headroom for positive airway pressure devices and home sleep testing kits. Advances in tuberculosis PCR kits with 100% sensitivity expand demand for portable diagnostic systems in public health laboratories. Together, these epidemiological shifts lengthen device replacement cycles and enlarge the Spain respiratory devices market far beyond acute care settings.

Rapid Ageing of Spain's Population

The cohort aged 90 years or older swelled 58.29% from 2013 to 2023, reaching 608,321 citizens. An ageing index of 142.35% highlights growing demand for non-invasive ventilation, oxygen concentrators, and airway clearance devices tailored to home use. With single-person households forecast to account for 33.5% of all households by 2039, manufacturers prioritise intuitive interfaces and remote monitoring features that let older adults remain independent. Hospitals already maintain dedicated non-invasive ventilation units in 83% of facilities, signalling sustained procurement for ageing-related disorders. These demographic realities embed structural growth in the Spain respiratory devices market.

High Upfront Cost of Advanced Devices

Hospitals operate under strict budget ceilings even after recent public-health outlays, causing extended procurement cycles for premium ventilators and AI-enabled monitors. Regional authorities lean on cost-per-quality-adjusted-life-year thresholds that favour proven mid-range products. The Canary Islands' decision to reduce its IGIC tax on medical devices to zero illustrates how targeted fiscal levers can mitigate affordability constraints. In the absence of nationwide VAT relief, price sensitivity will continue to cap immediate growth in the Spain respiratory devices market.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Home-based Respiratory Care and Tele-monitoring
2. Surge in e-cigarette-related Lung Injuries
3. EU MDR Compliance Delaying Product Launches

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Therapeutic devices accounted for 56.14% of 2025 revenue, reflecting a clinical preference for continuous airway pressure systems, ventilators, and oxygen concentrators. Positive airway pressure innovations such as KPAP enhance comfort and adherence among sleep apnea patients, locking in recurring mask and tubing sales. Ventilator development programs funded under national recovery schemes lower price barriers, further widening penetration. Nebulizers remain critical for COPD management, while portable oxygen systems support growing homecare demand. The Spain respiratory devices market size for therapeutic equipment is projected to rise in tandem with ageing-linked comorbidities.

Diagnostic and monitoring devices hold a smaller base but record the fastest 7.54% CAGR. Connected spirometers, wearable capnographs, and home sleep tests gain popularity amid wider telehealth rollouts. Early diagnosis of respiratory disease lowers hospital admissions, strengthening policy support for screening tools. As a result, diagnostic platforms capture a rising share of the Spain respiratory devices market.

Complete Report Scope:

• By Product Type
  • Diagnostic & Monitoring Devices
    • Spirometers
    • Sleep Test Devices
    • Peak Flow Meters
    • Other Diagnostic & Monitoring Devices
  • Therapeutic Devices
    • Positive Airway Pressure (PAP) Devices
    • Humidifiers
    • Nebulizers
    • Ventilators
    • Inhalers
    • Oxygen Concentrators
    • Other Therapeutic Devices
  • Disposables
    • Breathing Circuits
    • Masks
    • Filters
    • Other Disposables
• By Indication
  • COPD
  • Asthma
  • Sleep Apnea
  • Cystic Fibrosis
  • Tuberculosis
  • Other Respiratory Disorders
• By End User
  • Hospitals and Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Long-term Care Facilities

List of Companies Covered in this Report:

1. Koninklijke Philips
2. Resmed
3. Dragerwerk AG
4. Fisher & Paykel Healthcare
5. Medtronic
6. Hamilton Medical
7. GE Healthcare
8. Smiths Medical MD, Inc.
9. Fosun Pharma (Breas Medical AB)
10. Invacare
11. GlaxoSmithKline
12. Rotech Healthcare
13. Becton Dickinson & Co.
14. Air Liquide
15. Teleflex
16. Drive DeVilbiss Healthcare
17. Apex Medical
18. Lowenstein Medical GmbH
19. Vyaire Medical
20. Vapotherm Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Prevalence of COPD, Asthma, TB & Sleep-Apnea
  • 4.2.2 Rapid Ageing of Spain's Population
  • 4.2.3 Expansion of Home-Based Respiratory Care & Tele-Monitoring
  • 4.2.4 Surge In E-Cigarette-Related Lung Injuries
  • 4.2.5 Post-COVID Government Incentives for Local Ventilator Output
  • 4.2.6 Adoption of AI-Enabled Predictive Maintenance for Ventilators
• 4.3 Market Restraints
  • 4.3.1 High Upfront Cost of Advanced Devices
  • 4.3.2 EU MDR Compliance Delaying Product Launches
  • 4.3.3 Shortage of Respiratory Therapists
  • 4.3.4 Environmental Curbs on Single-Use Plastics In Disposables
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Product Type
  • 5.1.1 Diagnostic & Monitoring Devices
    • 5.1.1.1 Spirometers
    • 5.1.1.2 Sleep Test Devices
    • 5.1.1.3 Peak Flow Meters
    • 5.1.1.4 Other Diagnostic & Monitoring Devices
  • 5.1.2 Therapeutic Devices
    • 5.1.2.1 Positive Airway Pressure (PAP) Devices
    • 5.1.2.2 Humidifiers
    • 5.1.2.3 Nebulizers
    • 5.1.2.4 Ventilators
    • 5.1.2.5 Inhalers
    • 5.1.2.6 Oxygen Concentrators
    • 5.1.2.7 Other Therapeutic Devices
  • 5.1.3 Disposables
    • 5.1.3.1 Breathing Circuits
    • 5.1.3.2 Masks
    • 5.1.3.3 Filters
    • 5.1.3.4 Other Disposables
• 5.2 By Indication
  • 5.2.1 COPD
  • 5.2.2 Asthma
  • 5.2.3 Sleep Apnea
  • 5.2.4 Cystic Fibrosis
  • 5.2.5 Tuberculosis
  • 5.2.6 Other Respiratory Disorders
• 5.3 By End User
  • 5.3.1 Hospitals and Clinics
  • 5.3.2 Homecare Settings
  • 5.3.3 Ambulatory Surgical Centers
  • 5.3.4 Long-term Care Facilities

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Koninklijke Philips N.V.
  • 6.3.2 ResMed
  • 6.3.3 Dragerwerk AG
  • 6.3.4 Fisher & Paykel Healthcare Ltd
  • 6.3.5 Medtronic plc
  • 6.3.6 Hamilton Medical AG
  • 6.3.7 GE HealthCare
  • 6.3.8 Smiths Medical MD, Inc.
  • 6.3.9 Fosun Pharma (Breas Medical AB)
  • 6.3.10 Invacare Corporation
  • 6.3.11 GlaxoSmithKline plc
  • 6.3.12 Rotech Healthcare Inc.
  • 6.3.13 Becton Dickinson & Co.
  • 6.3.14 Air Liquide Healthcare
  • 6.3.15 Teleflex Inc.
  • 6.3.16 DeVilbiss Healthcare LLC
  • 6.3.17 Apex Medical Corp.
  • 6.3.18 Lowenstein Medical GmbH
  • 6.3.19 Vyaire Medical Inc.
  • 6.3.20 Vapotherm Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment